Predictors of Disease Severity in COVID-19 Patients

NCT04887142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 818

Last updated 2026-04-28

No results posted yet for this study

Summary

The primary goal of the VIRIONUM project is to analyze the association of clinical, socio-demographic characteristics of patients and their genetic polymorphism, inflammatory and other biochemical markers with disease progression and death in subjects with COVID-19 disease. The research is an observational, cohort study with nested-case control design, including adult, male and female COVID-19 inpatients. Primary dependent variable will be outcome of disease, defined as discharge from the hospital or death. The outcomes and putative risk factors will be analyzed using binary logistic regressions. The proposed multi- and inter-disciplinary study should provide additional scientific evidence about risk factors for the development of severe forms of the disease and the COVID-19-related death.

Conditions

Interventions

OTHER

Standard of health care

The patients in this observational study will be exposed to the standard health care interventions according to the hospital diagnostic and treatment protocols and procedures and clinical judgment of the treating physicians.

Sponsors & Collaborators

  • Zeljko Mijailovic

    lead OTHER

Principal Investigators

  • Dejan Baskic, MD PHD · Faculty of Medical Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-04
Primary Completion
2023-05-12
Completion
2024-02-29

Countries

  • Albania
  • Bosnia and Herzegovina
  • Croatia
  • Montenegro
  • Serbia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04887142 on ClinicalTrials.gov